Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Chooses Abzena As Partner For Clinical Trial Phase 2

Feb 3 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * CHOOSES ENGLISH ABZENA LTD. AS PARTNER FOR MANUFACTURING
OF DRUG
SUBSTANCE FOR CLINICAL TRIAL PHASE 2
    * COLLABORATION INCLUDES DELIVERY FOR CLINICAL TRIALS
    * LONG-TERM STRATEGY IS FOR ABZENA TO BE CORLINE'S FUTURE
COMMERCIAL SUPPLIER

Source text for Eikon:  ID:nGNEcdFjCG 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Corline Biomedical AB

See all news